Physician

Salim B Mathew, MD,MBA

According to 2025 Medicare claims, Salim Mathew, MD, MBA (NPI: 1861468449) practices interventional cardiology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is CARDIOVASCULAR ASSOCIATES OF CHARLOTTESVILLE, PLC (NPI: 1891865622; TIN: 205577233) and primary practice location at 22911-8844. Mathew is affiliated with the Augusta Care Partners, LLC (ACO ID: A2266), participating under the MSSP model.

Mathew's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,593 traditional Medicare patients, billed 4,583 HCPCS/CPT codes, and received $299,446 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 2,284 prescription claims across 435 beneficiaries totaling $578,211 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 56 claims. Open Payments data shows 13 records totaling $1,908. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $223,660 to $578,211. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	945	4,484	$303,023
2016	774	3,746	$251,778
2017	1,272	3,285	$250,098
2018	1,333	3,490	$289,706
2019	1,397	4,241	$321,838
2020	1,697	4,955	$361,211
2021	1,659	5,202	$393,171
2022	1,521	4,745	$357,720
2023	1,639	4,749	$346,306
2024	1,593	4,583	$299,446

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	385	2,328	$223,660
2016	422	2,445	$343,842
2017	381	1,838	$249,115
2018	179	523	$101,324
2019	172	858	$210,081
2020	239	1,190	$257,606
2021	312	1,721	$362,091
2022	377	1,960	$451,817
2023	396	2,091	$535,662
2024	435	2,284	$578,211

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	291	$269,288
2016	N/R	319	$288,068
2017	N/R	56	$37,525
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	117	117	$241
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	556	560	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	641	1,172	$82
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	617	864	$9
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	143	149	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	343	21,802	$415,467
Xarelto	Rivaroxaban	39	2,730	$48,548
Entresto	Sacubitril/Valsartan	44	2,004	$45,469
Brilinta	Ticagrelor	13	1,110	$16,116
Repatha Sureclick	Evolocumab	25	784	$15,582

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$1,908	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Salim B. Mathew, MD, MBA?

Tedicare shows public-source Medicare data for Salim B. Mathew, MD, MBA (NPI 1861468449), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Salim B. Mathew, MD, MBA have ACO affiliation data?

Salim B. Mathew, MD, MBA is shown with ACO affiliation data for Augusta Care Partners, LLC (MSSP, ACO ID A2266).

What billing organization is linked to Salim B. Mathew, MD, MBA?

Salim B. Mathew, MD, MBA is linked to CARDIOVASCULAR ASSOCIATES OF CHARLOTTESVILLE, PLC (billing NPI 1891865622) in the available physician profile data.

Does Salim B. Mathew, MD, MBA have Open Payments data?

Salim B. Mathew, MD, MBA has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.